EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Concurrent active pulmonary tuberculosis and small cell lung cancer: diagnostic challenges and therapeutic insights from a case report

Meiling Sun, Huaijun Ji, Ailing Liu, Ning Xu

Frontiers in Oncology · 04.09.2025 · 15

DOI: 10.3389/fonc.2025.1564686 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 04.09.2025. Verfasst von Meiling Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, Shandong, …. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The coexistence of active pulmonary tuberculosis (TB) and small cell lung cancer (SCLC) is an exceptionally rare clinical phenomenon, presenting significant diagnostic and therapeutic challenges due to overlapping symptoms, radiological findings, and drug interactions. We report the case of a 68-year-old male with a four-month diagnostic journey, involving persistent cough, exertional chest tightness, and multiple inconclusive bronchoscopic examinations. Active TB was confirmed via sputum smear tests identifying acid-fast bacilli, while SCLC was diagnosed later through a third bronchoscopy, supported by elevated progastrin-releasing peptide (ProGRP, 127.28 pg/mL). The patient received a two-month course of anti-TB therapy before initiating four cycles of etoposide-cisplatin chemotherapy, followed by chest radiotherapy. Anti-TB treatment was intermittently paused during chemotherapy cycles to minimize drug interactions, and the patient completed 11 months of therapy. Follow-up imaging showed partial resolution of the left upper lung lesion, with normalized tumor markers (ProGRP: 66.20 pg/mL). However, at 17 months, disease progression was noted with a metastatic lesion in the right lower lobe. This case underscores the complex interplay between TB-induced chronic inflammation and tumor progression, highlighting the need for early tumor marker testing, advanced imaging modalities such as PET-CT, and tailored therapeutic strategies. Multidisciplinary collaboration is critical for optimizing outcomes in such rare and challenging scenarios. Further research into the mechanistic links between TB and SCLC could improve early diagnosis, guide therapeutic decisions, and inform preventive strategies.

Schlagwörter

Stichwörter der Autor:innen

Small cell lung cancercase reportdiagnostic challengesmultidisciplinary collaborationpulmonary tuberculosis

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, Shandong, China.
  • Department of Thoracic Surgery, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, Shandong, China.

Zitieren

APA

Sun, M., Ji, H., Liu, A., & Xu, N. (2025). Concurrent active pulmonary tuberculosis and small cell lung cancer: diagnostic challenges and therapeutic insights from a case report. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1564686

Vancouver

Sun M, Ji H, Liu A, Xu N. Concurrent active pulmonary tuberculosis and small cell lung cancer: diagnostic challenges and therapeutic insights from a case report. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1564686

BibTeX
@article{Sun2025,
  author = {Sun, Meiling and Ji, Huaijun and Liu, Ailing and Xu, Ning},
  title = {Concurrent active pulmonary tuberculosis and small cell lung cancer: diagnostic challenges and therapeutic insights from a case report},
  journal = {Frontiers in Oncology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fonc.2025.1564686}
}
Kostenlos starten →